Evidence map›Paper›PMID 26084519›Full record

ReviewProtein & cell2015

A peep into mitochondrial disorder: multifaceted from mitochondrial DNA mutations to nuclear gene modulation.

Chao Chen, Ye Chen, Min-Xin Guan

Open access · diamondAbstract readReview
In one paragraph

Review in Protein & cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Super-resolution imaging forActa pharmaceutica Sinica. B · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. mt tRFs, New Players in MELAS Disease.Frontiers in physiology · 2022
    Article
  11. Review
  12. Review
  13. Frequency and spectrum ofMitochondrial DNA. Part B, Resources · 2019
    Article
  14. Review
  15. Article
  16. Review
  17. Contribution of the tRNAThe Journal of biological chemistry · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chao ChenSchool of Medicine, Institute of Genetics, Zhejiang University, Hangzhou, 310058, China.
Ye ChenSchool of Medicine, Institute of Genetics, Zhejiang University, Hangzhou, 310058, China. yechency@zju.edu.cn.
Min-Xin GuanSchool of Medicine, Institute of Genetics, Zhejiang University, Hangzhou, 310058, China.
Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial genome is responsible for multiple human diseases in a maternal inherited pattern, yet phenotypes of patients in a same pedigree frequently vary largely. Genes involving in epigenetic modification, RNA processing, and other biological pathways, rather than "threshold effect" and environmental factors, provide more specific explanation to the aberrant phenotype. Thus, the double hit theory, mutations both in mitochondrial DNA and modifying genes aggravating the symptom, throws new light on mitochondrial dysfunction processes. In addition, mitochondrial retrograde signaling pathway that leads to reconfiguration of cell metabolism to adapt defects in mitochondria may as well play an active role. Here we review selected examples of modifier genes and mitochondrial retrograde signaling in mitochondrial disorders, which refine our understanding and will guide the rational design of clinical therapies.

Indexed as

MutationAnimalsCell NucleusDNA, MitochondrialHumansMitochondrial DiseasesSignal TransductionDNA, Mitochondrialmitochondrial disordermitochondrial DNA mutationmitochondrial retrograde signalingnuclear modifier gene

Identifiers

PMID26084519
PMCPMC4656216
OpenAlexW2169176816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.